{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:30:17Z","timestamp":1790638217624,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007776","name":"Deanship of Academic Research, University of Jordan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005712","name":"University of Jordan","doi-asserted-by":"publisher","award":["Jordan"],"award-info":[{"award-number":["Jordan"]}],"id":[{"id":"10.13039\/501100005712","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jgar.2018.04.004","type":"journal-article","created":{"date-parts":[[2018,4,14]],"date-time":"2018-04-14T11:58:50Z","timestamp":1523707130000},"page":"185-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Evaluation of four calcium channel blockers as fluconazole resistance inhibitors in Candida glabrata"],"prefix":"10.1016","volume":"14","author":[{"given":"Lina M.","family":"Alnajjar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6754-0325","authenticated-orcid":false,"given":"Nailya R.","family":"Bulatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rula M.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2018.04.004_bib0005","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/AAC.48.10.3773-3781.2004","article-title":"Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor","volume":"48","author":"Vermitsky","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.04.004_bib0010","first-page":"148","article-title":"In silico modeling and docking of Cch1 protein of Candida glabrata with FDA-approved drugs: a drug repurposing approach","volume":"9","author":"Ahmad","year":"2016","journal-title":"Asian J Pharm Clin Res"},{"key":"10.1016\/j.jgar.2018.04.004_bib0015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/myc.12348","article-title":"Candida glabrata\u2014unique features and challenges in the clinical management of invasive infections","volume":"58","author":"Gl\u00f6ckner","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2018.04.004_bib0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/524071","article-title":"Resistance to antifungal agents: mechanisms and clinical impact","volume":"46","author":"Kanafani","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2018.04.004_bib0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/CMR.00051-08","article-title":"Efflux-mediated antifungal drug resistance","volume":"22","author":"Cannon","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2018.04.004_bib0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1124\/dmd.104.002089","article-title":"New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as P-glycoprotein inhibitors","volume":"33","author":"Zhou","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jgar.2018.04.004_bib0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000112964","article-title":"Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans","volume":"17","author":"Bulatova","year":"2008","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.jgar.2018.04.004_bib0040","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; fourth informational supplement. Document M27-S4","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.jgar.2018.04.004_bib0045","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/AAC.00999-09","volume":"54","author":"Meletiadis","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.04.004_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.04.004_bib0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fmicb.2015.00330","article-title":"Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant Mycobacterium tuberculosis clinical isolates from Brazil","volume":"6","author":"Coelho","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2018.04.004_bib0060","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1099\/jmm.0.47651-0","article-title":"Synergistic activity of azoles with amiodarone against clinically resistant Candida albicans tested by chequerboard and time\u2013kill methods","volume":"57","author":"Guo","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2018.04.004_bib0065","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1128\/AAC.41.10.2229","article-title":"Molecular biological characterization of an azole-resistant Candida glabrata isolate","volume":"41","author":"Marichal","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.04.004_bib0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10096-013-2009-3","article-title":"Candida glabrata: a review of its features and resistance","volume":"33","author":"Rodrigues","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2018.04.004_bib0075","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1128\/AAC.43.11.2753","article-title":"The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents","volume":"43","author":"Sanglard","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.04.004_bib0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1570-0232(02)00668-2","article-title":"Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole","volume":"782","author":"Niimi","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jgar.2018.04.004_bib0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/EC.00271-14","article-title":"Components of the calcium\u2013calcineurin signaling pathway in fungal cells and their potential as antifungal targets","volume":"14","author":"Liu","year":"2015","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.jgar.2018.04.004_bib0090","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/AAC.49.2.668-679.2005","article-title":"Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance","volume":"49","author":"Sanguinetti","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.04.004_bib0095","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1128\/AAC.39.8.1696","article-title":"Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata","volume":"39","author":"Parkinson","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.04.004_bib0100","first-page":"1","article-title":"Human ABCG2: structure, function, and its role in multidrug resistance","volume":"3","author":"Mo","year":"2012","journal-title":"Int J Biochem Mol Biol"},{"key":"10.1016\/j.jgar.2018.04.004_bib0105","first-page":"40","article-title":"In vitro antimicrobial activity of 18 phenothiazine derivatives: structure\u2013activity relationship","volume":"30","author":"Bourlioux","year":"1992","journal-title":"APMIS Suppl"},{"key":"10.1016\/j.jgar.2018.04.004_bib0110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3742\/OPEM.2006.6.2.126","article-title":"Assessment of antibacterial activity of the cardiovascular drug nifedipine","volume":"6","author":"Pal","year":"2006","journal-title":"Orient Pharm Exp Med"},{"key":"10.1016\/j.jgar.2018.04.004_bib0115","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.drudis.2009.08.004","article-title":"Dihydropyridines: evaluation of their current and future pharmacological applications","volume":"14","author":"Edraki","year":"2009","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jgar.2018.04.004_bib0120","first-page":"75","article-title":"1,4-Dihydropyridines: a multifunctional molecule\u2014a review","volume":"3","author":"Swarnalatha","year":"2011","journal-title":"Int J ChemTech Res"},{"key":"10.1016\/j.jgar.2018.04.004_bib0125","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1128\/AAC.48.4.1335-1343.2004","article-title":"Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole","volume":"48","author":"Afeltra","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.04.004_bib0130","article-title":"Synergistic effect of fluconazole and calcium channel blockers against resistant Candida albicans","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"issue":"June 23","key":"10.1016\/j.jgar.2018.04.004_bib0135","article-title":"Antihypertensive, amlodipine besilate inhibits growth and biofilm of human fungal pathogen Candida","author":"Gupta","year":"2016","journal-title":"Assay Drug Dev Technol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518300717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518300717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:52:39Z","timestamp":1761990759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716518300717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":27,"alternative-id":["S2213716518300717"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2018.04.004","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of four calcium channel blockers as fluconazole resistance inhibitors in Candida glabrata","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2018.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}